Thermo Fisher Scientific Inc.  

(Public, NYSE:TMO)   Watch this stock  
Find more results for Pro Tool and Design Inc
+1.14 (0.94%)
Jul 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 120.35 - 122.27
52 week 88.13 - 127.63
Open 120.46
Vol / Avg. 0.00/1.90M
Mkt cap 48.73B
P/E 31.18
Div/yield 0.15/0.49
EPS 3.92
Shares 398.94M
Beta 0.94
Inst. own 92%
Jul 23, 2014
Q2 2014 Thermo Fisher Scientific Earnings Release - 9:30AM EDT - Add to calendar
Jul 23, 2014
Q2 2014 Thermo Fisher Scientific Inc Earnings Call - 8:30AM EDT - Add to calendar
Jun 17, 2014
Thermo Fisher Scientific Inc at Wells Fargo Healthcare Conference ( 1:1 meeting)
Jun 10, 2014
Thermo Fisher Scientific Inc at Goldman Sachs Healthcare Conference
May 20, 2014
Thermo Fisher Scientific Annual Shareholder Meeting
May 20, 2014
Thermo Fisher Scientific Analyst Meeting
May 13, 2014
Thermo Fisher Scientific at Bank of America Merrill Lynch Health Care Conference
Apr 23, 2014
Q1 2014 Thermo Fisher Scientific Earnings Release
Apr 23, 2014
Q1 2014 Thermo Fisher Scientific Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 13.91% 9.77%
Operating margin 22.43% 12.30%
EBITD margin - 21.31%
Return on average assets 5.59% 4.31%
Return on average equity 11.68% 7.92%
Employees 50,000 -
CDP Score - 75 D


81 WYMAN ST, PO Box 9046
United States - Map
+1-781-6221000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services. The Company serves its customers through three brands: Thermo Scientific, Fisher Scientific and Unity Lab Services. Thermo Scientific is its technology brand, offering customers a range of high-end analytical instruments, as well as laboratory equipment, software, services, consumables and reagents to enable laboratory workflow solutions. In March 2014, General Electric Co announced that its GE Healthcare, a unit of General Electric Company has acquired cell culture (sera and media), gene modulation and magnetic beads businesses from Thermo Fisher Scientific Inc.

Officers and directors

Jim P. Manzi Independent Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Marc N. Casper President, Chief Executive Officer, Director
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter M. Wilver Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alan J. Malus Executive Vice President, President, Laboratory Products and Services
Age: 54
Bio & Compensation  - Reuters
Mark P. Stevenson Executive Vice President, President, Life Sciences Solutions
Age: 51
Bio & Compensation  - Reuters
Seth H. Hoogasian Senior Vice President, General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Thomas W. Loewald Senior Vice President, President - Analytical Instruments
Age: 50
Bio & Compensation  - Reuters
Edward A. Pesicka Senior Vice President, Chief Commercial Officer
Age: 46
Bio & Compensation  - Reuters
Andrew J. Thomson Senior Vice President, President - Specialty Diagnostics
Age: 49
Bio & Compensation  - Reuters
Peter E. Hornstra Vice President, Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance